We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Fibrinogen-Albumin Ratio Correlated to Ankylosing Spondylitis Disease Activity

By LabMedica International staff writers
Posted on 23 Mar 2020
Ankylosing spondylitis (AS) is a systematic inflammatory autoimmune disease that primarily involves the spine and sacroiliac joints. More...
Typically the joints where the spine joins the pelvis are also affected and occasionally other joints such as the shoulders or hips are involved. Back pain is a characteristic symptom of AS, and it often comes and goes.

Some simple and cost-effective inflammatory indicators for AS, such as neutrophils to lymphocytes ratio (NLR), platelets to lymphocytes ratio (PLR) and monocytes to lymphocytes ratio (MLR) have been explored. Fibrinogen (Fib) is a critical factor involved in the coagulation system, which has been reported to be increased in AS patients compared with controls and significantly correlated with C-reactive protein (CRP).

Rheumatologists and Immunologists at the Guangdong Second Provincial General Hospital (Guangzhou, China) performed a retrospective study that included 135 AS patients that visited from March 2016 and June 2019. Seventy-six age- and sex-matched healthy subjects from the Department of Physical Examination Center who had no evidence of illness were enrolled in the control group at the same period.

Clinical characteristics included human leukocyte antigen (HLA)-B27 status, number of white blood cells (WBCs), lymphocytes, neutrophils, monocytes, platelets (PLT), red blood cell distribution width (RDW), Fib, albumin (ALB), globulin (GLB), CRP and erythrocyte sedimentation rate (ESR) level were collected. neutrophil to lymphocyte ratio (NLR), monocyte to lymphocytes ratio (MLR), platelet-lymphocyte ratio (PLR) and fibrinogen to albumin ratio (FAR) were calculated. All the peripheral venous blood samples were taken after an overnight fast of at least eight hours.

The investigators reported that AS patients showed higher FAR levels than the controls. FAR was also increased in active group of AS patients than those in inactive group. Spearman analyses showed that FAR was positively related with Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in AS patients. ROC curve analyses revealed that the AUC of FAR was higher than ALB and Fib. In addition, the optimal cutoff value of FAR for AS diagnosis was 78.84, with a specificity of 88.2% and sensitivity of 77.0%. Logistical regression analyses showed that FAR (odds ratio = 13.091) was a predictor for AS disease activity.

The authors concludes that their study showed that FAR was increased in AS patients and significantly positively correlated with AS disease activity. High FAR was revealed as an adverse predictor for the disease activity in AS patients. The study indicated that FAR may be a novel biomarker for reflecting disease activity in AS patients. The study was published on February 26, 2020 in the journal Clinica Chimica Acta.

Related Links:
Guangdong Second Provincial General Hospital


Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
Urine Analyzer
respons® UDS100
Automated Coagulation Analyzer
Hemolumi H6
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The approach supports myocardial infarction diagnosis in resource-limited settings by reducing delays between clinical suspicion and biochemical confirmation (Image Credit: Adobe Stock)

Portable Troponin Assay Brings Heart Attack Diagnosis Closer to Patients

Timely confirmation of myocardial infarction often depends on laboratory testing that may not be immediately available at the point of care. This gap between clinical suspicion and definitive evidence... Read more

Molecular Diagnostics

view channel
Image: The two new tests are used with the LightCycler 480 and LightCycler PRO instruments (Photo courtesy of Roche)

New PCR Assays Expand Cyclospora Testing for Outbreak Surveillance

Cyclospora cayetanensis, a food- and waterborne intestinal parasite, can cause prolonged diarrhea, fatigue, and abdominal cramping, placing added strain on urgent care and emergency departments during outbreaks.... Read more

Immunology

view channel
Image: Graphical Abstract (Morgane Fournier et al., Cell (2026). DOI: 10.1016/j.cell.2026.04.013)

Study Reveals Immune Mechanism Driving Severe COVID-19 Progression

Severe COVID-19 has highlighted gaps in understanding of early antiviral responses, particularly why some patients deteriorate despite timely care. Type I interferons are central to host defense, yet their... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.